Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Cervical Cancer, October 2025

Free Subscription


Abstracts

Retrieve all available abstracts of the following 203 articles:
HTML format


 

Single Articles

  1. ASLAN B, Onal O
    Factors influencing the decision to undergo cervical cancer screening tests (Pap Smear and HPV-DNA testing) in women aged 30-65: The role of HPV knowledge, cancer screening perception, health anxiety, and behaviors for protection against sexually tran
    J Health Psychol. 2025 Oct 3:13591053251376855. doi: 10.1177/13591053251376855.
    PubMed    
    Abstract available

  2. LEE J, Lim H, Baek IW, Chung MK, et al
    Cervical cancer screening rates in Korean women of childbearing age with systemic lupus erythematosus.
    Lupus. 2025 Oct 3:9612033251386086. doi: 10.1177/09612033251386086.
    PubMed    
    Abstract available

  3. RIVERO-MENDOZA D, Gjoka K, Singh L, Adkins L, et al
    Health System Strategies to Improve the Uptake of Cervical Cancer Screening in Sub-Saharan Africa: A Scoping Systematic Review.
    Health Promot Pract. 2025 Oct 3:15248399251370668.
    PubMed    
    Abstract available

  4. MOUKAM AMD, Salah N, Tankeu Happi GW, Metchehe LDD, et al
    Acceptability of home-based HPV self-sampling for cervical cancer screening among users and providers in the West region of Cameroon: a cross-sectional study.
    BMC Health Serv Res. 2025;25:1303.
    PubMed    
    Abstract available

  5. FENG S, Gunawan R, Passey C, Voellinger J, et al
    Exposure-safety Markov modeling of ocular adverse events in patient populations treated with tisotumab vedotin.
    J Pharmacokinet Pharmacodyn. 2025;52:55.
    PubMed    
    Abstract available

  6. JAYAKUMAR B, Ngua Roca A, Teklemichael L, Ondo Oyono M, et al
    Lessons Learned From 7 Years of Implementing Cervical Cancer Screening and Treatment in Equatorial Guinea.
    JCO Glob Oncol. 2025;11:e2400658.
    PubMed    
    Abstract available

  7. NGUYEN VT, Arockiam S, Kumar P, Eger J, et al
    Diagnostic Translational Considerations for Global Health Settings: Portable Detection of Human Papillomavirus for Cervical Cancer Screening in India.
    JCO Glob Oncol. 2025;11:e2500117.
    PubMed    
    Abstract available

  8. ASEMPAH E, Ikpebe E, Wyndham-West M, Wiktorowicz ME, et al
    Challenges and Opportunities for Cervical Cancer Prevention Through HPV Vaccination in Ghana: A Public Health Policy Analysis.
    Cancer Control. 2025;32:10732748251383280.
    PubMed    
    Abstract available

  9. KAPLAN C, Crane L, Collins A, Parker RL, et al
    At-home self-collection device offers an effective and preferred method to engage high BMI women in cervical cancer screening: method comparison study.
    Arch Gynecol Obstet. 2025 Oct 3. doi: 10.1007/s00404-025-08189.
    PubMed    
    Abstract available

  10. WANG K, Sun J, Zhang H, Li L, et al
    Research on the Effect of NK Cells Based on Functionalized Magnetic Beads on Cervical Cancer Mice.
    ACS Appl Bio Mater. 2025 Oct 3. doi: 10.1021/acsabm.5c00811.
    PubMed    
    Abstract available

  11. ZHANG N
    Early detection and management strategies for isolated splenic metastasis in cervical cancer: a case report.
    Front Oncol. 2025;15:1639109.
    PubMed    
    Abstract available

  12. SUTRISNO S, Marlina D, Dewi Poernomo MAP, Utomo A, et al
    Elevated Body Mass Index as a Predictor of Cervical Cancer and Precancerous Lesions.
    Med Sci Monit. 2025;31:e947820.
    PubMed    
    Abstract available

  13. BARMON D, Nath A, Aparajita, Sharma JD, et al
    Advocacy to action for cervical cancer elimination in the state of Assam: a narrative review of the government policies and the latest report of NCDIR survey.
    BMC Health Serv Res. 2025;25:1291.
    PubMed    
    Abstract available

  14. QUAN C, Jiang P, Gao G, Wang Z, et al
    Mesoporous silica-coated gold nanorod grafted with cisplatin prodrug on the surface enhances radiotherapy for cervical cancer via triple-strategy approach.
    Colloids Surf B Biointerfaces. 2025;257:115160.
    PubMed    
    Abstract available

  15. MARINO JM, Silva CM, Silva UAOD, Wanderley LC, et al
    Facilitators and barriers to the Papanicolaou test on women in countryside of Amazonas.
    Rev Gaucha Enferm. 2025;46.
    PubMed    
    Abstract available

  16. THAKER PH, Lu H, Zhang YJ, Trapali M, et al
    Treatment preferences of patients with recurrent or metastatic cervical cancer: a discrete choice experiment in the US.
    Gynecol Oncol Rep. 2025;61:101947.
    PubMed    
    Abstract available

  17. SU Q, Tian X, Li F, Yu X, et al
    Integrated multi-omics analysis of single-cell and spatial transcriptomics reveals distinct hpv-associated immune microenvironment features and prognostic signatures in cervical cancer.
    Front Immunol. 2025;16:1612623.
    PubMed    
    Abstract available

  18. SHARMA M, Chourasia N, Priyanka P, Sarkar DP, et al
    Functional characterization of dysregulated LncRNAs in BRCA and CESC highlights their role in cancer prognosis.
    Sci Rep. 2025;15:34265.
    PubMed    
    Abstract available

  19. MAQBOOL T, Hadi F, Naz S, Inamullah, et al
    Pulegone induced apoptotic and anti-proliferative potential in cervical cancer via P53, BAX and BCL2.
    Sci Rep. 2025;15:34217.
    PubMed    
    Abstract available

  20. MEENAN RT, Lacey C, Buist DSM, Tiro JA, et al
    Cost-Effectiveness of HPV Self-Testing Options for Cervical Cancer Screening.
    JAMA Netw Open. 2025;8:e2534960.
    PubMed    
    Abstract available

  21. DUHORANENAYO D, Nyiraneza SE, Rugengamanzi E, Sungura R, et al
    Treatment response after chemoradiation with an external beam radiation therapy boost in cervical cancer patients in Rwanda.
    Oncologist. 2025 Oct 1:oyaf328. doi: 10.1093.
    PubMed    
    Abstract available

  22. HU S, Lu Y, Pandey P, Mujtaba MA, et al
    Oroxylin A exerts antiproliferative effects through downregulation of E6 and E7 oncogenes in cervical cancer HeLa cells.
    Naunyn Schmiedebergs Arch Pharmacol. 2025 Oct 1. doi: 10.1007/s00210-025-04601.
    PubMed    
    Abstract available

  23. SATOH M, Sato N, Sekino M
    Behavioral economics, lifestyle, and health-related factors associated with participation in breast and cervical cancer screenings: A cross-sectional analysis of Japanese women.
    Prev Med Rep. 2025;59:103249.
    PubMed    
    Abstract available

  24. CHEN J, Zhang M, Gong Y, Gu Z, et al
    The Role of the Vaginal Microbiome in Immune Modulation in Cervical Cancer: Composition, Molecular Mechanisms, and Therapeutic Potential.
    Clin Med Insights Oncol. 2025;19:11795549251380470.
    PubMed    
    Abstract available

  25. TAKAHASHI T, Kobayashi Y, Sakurai R, Matsuoka K, et al
    A Systematic Review of the Application of Artificial Intelligence in Colposcopy: Diagnostic Accuracy for Cervical Intraepithelial Neoplasia and Cervical Cancer.
    Clin Med Insights Oncol. 2025;19:11795549251374908.
    PubMed    
    Abstract available

  26. BAN R, Zeng J, Hao J
    Dosimetric study on the effect of minimum distance between optimization structures and planning target volume on small intestine dose in cervical cancer VMAT plans.
    Medicine (Baltimore). 2025;104:e44715.
    PubMed    
    Abstract available

  27. YAN Y, Zhang L, Yuan S, Zhang T, et al
    Association between the oxidative balance score and gynecologic cancers from the National Health and Nutrition Examination Survey: An observational study.
    Medicine (Baltimore). 2025;104:e44782.
    PubMed    
    Abstract available

  28. CHOUDHARY S, Pandey A, Singh A, Mourya A, et al
    Comparison of intravaginal and interstitial brachytherapy in cervical cancer after inadvertent hysterectomy: a retrospective study.
    Sci Rep. 2025;15:33784.
    PubMed    
    Abstract available

  29. LIU C, Ding L, Chen S, Liu L, et al
    Enhancing Sonodynamic Therapy for Cervical Cancer Using Ultrasound-Activated BTO@PEG.
    Mol Pharm. 2025 Sep 30. doi: 10.1021/acs.molpharmaceut.5c00765.
    PubMed    
    Abstract available

  30. HONORE I, Bargisen M, Knudsen AS, Lyngso J, et al
    [Postcoital bleeding in premenopausal women].
    Ugeskr Laeger. 2025;187:V03250162.
    PubMed    
    Abstract available

  31. YAO S, Chen S, Wan S, Wang A, et al
    LAG3 as a Tumor Suppressor and Immune Regulator in Cervical Cancer: From Functional Validation to Therapeutic Strategy.
    Cancer Med. 2025;14:e71278.
    PubMed    
    Abstract available

  32. SONG L, Qin K, Bai S, Wu Q, et al
    Establishment and verification of a nomogram model based on the inflammatory indicators of patients with cervical cancer for predicting the risk of their lymph node metastasis.
    PeerJ. 2025;13:e20069.
    PubMed    
    Abstract available

  33. HE XY, Huang Y, Qiao CP, Ma J, et al
    Fertility anxiety partially mediates depression and recurrence fear in reproductive-age cervical cancer patients: A cross-sectional study.
    World J Clin Oncol. 2025;16:110031.
    PubMed    
    Abstract available

  34. DONG M, Xie J, Zhao X, Zhao F, et al
    Impact of government-organized screening programs on the economic burden of cervical cancer across five disease courses: a multistage regression and mediation analysis.
    Cancer Biol Med. 2025 Sep 29:j.issn.2095-3941.2025.0418.
    PubMed    
    Abstract available

  35. JIA X, Gao C, Da X, Shi J, et al
    Evaluation of an intelligent digital platform for population management in cervical cancer screening.
    Cancer Biol Med. 2025 Sep 29:j.issn.2095-3941.2025.0419.
    PubMed    
    Abstract available

  36. BASU P
    Progress toward cervical cancer elimination: global disparities and China's contributions.
    Cancer Biol Med. 2025 Sep 29:j.issn.2095-3941.2025.0428.
    PubMed    


  37. WANG M, Xu J, Xu S, Wu Y, et al
    The primary surgery improved the survival of FIGO stage IIIC1 cervical cancer with T1b-T2a tumors.
    BMC Womens Health. 2025;25:454.
    PubMed    
    Abstract available

  38. FENG T, Zhang W, Zhao T, Zhou S, et al
    Comparative analysis of preoperative and postoperative HPV infection dynamics in patients with cervical intraepithelial neoplasia and cervical cancer: implications for screening and management.
    BMC Infect Dis. 2025;25:1195.
    PubMed    
    Abstract available

  39. FENG S, Zhao M, Zhang D, Zhang Y, et al
    TUFT1 regulates cancer progression by suppressing centrosome amplification and mitotic spindle multipolarity.
    Cell Death Dis. 2025;16:673.
    PubMed    
    Abstract available

  40. KUIPERS SC, van Tuyll van Serooskerken M, Lathouwers D, Corbeau A, et al
    Predicting lymphocyte dose and surviving fraction for VMAT and IMPT treatments with a dynamic lymphocyte flow model for locally advanced cervical cancer.
    Phys Med Biol. 2025 Sep 29. doi: 10.1088/1361-6560.
    PubMed    
    Abstract available

  41. LE THI P, Nguyen HT, Quoc Nguyen V, Tran Nguyen H, et al
    Enhanced Cytotoxicity of Cisplatin-Loaded Brij S100-Alginate-Taurine Nanogels Against HeLa Cervical Cancer Cells.
    Nanotechnology. 2025 Sep 29. doi: 10.1088/1361-6528.
    PubMed    
    Abstract available

  42. SOLER M, Alfaro K, Rauda JC, Torres E, et al
    Adoption and Implementation of Affordable Cancer Technologies in El Salvador: Identifying Implementation Strategies for Successful Cervical Cancer Prevention in Resource-Limited Settings.
    JCO Glob Oncol. 2025;11:e2500065.
    PubMed    
    Abstract available

  43. AZIM MR, Wong EYT, Rahman MM, Islam MS, et al
    Knowledge, Attitudes, and Health-Seeking Behavior for Cervical, Breast, and Oral Cancers Among Women in Jashore, Bangladesh: A Cross-Sectional Study.
    JCO Glob Oncol. 2025;11:e2500304.
    PubMed    
    Abstract available

  44. LI J, Wang Y, Pei J, Wang M, et al
    Low pre-treatment neutrophil-to-lymphocyte ratio predicted a better survival in recurrent/metastatic cervical cancer treated with PD-1/PD-L1 inhibitors.
    Discov Oncol. 2025;16:1756.
    PubMed    
    Abstract available

  45. ZACAPALA-GOMEZ AE, Hernandez-Galicia G, Torres-Rojas FI, Banos-Hernandez CJ, et al
    Let-7c/RUNX1 Axis Promotes Cervical Cancer: A Bioinformatic Analysis.
    Curr Issues Mol Biol. 2025;47:757.
    PubMed    
    Abstract available

  46. VARESANO S, Ciccarese G, Parente P, Paudice M, et al
    Integrating Molecular Diagnostics into Cervical Cancer Screening: A Workflow Using FFPE Tissue Samples.
    Curr Issues Mol Biol. 2025;47:679.
    PubMed    
    Abstract available

  47. QIU Z, Yu X, Wang T
    Differential cardiovascular outcomes of radiotherapy in rectal, breast, and cervical cancer: insights from a SEER data analysis.
    Radiat Prot Dosimetry. 2025 Sep 29:ncaf111. doi: 10.1093.
    PubMed    
    Abstract available

  48. LIU B, Bao Y, Ma J, Wang X, et al
    Clinical Efficacy of Hydrogen Therapy on Acute Radiation Enteritis and Inflammatory Response in Patients with Cervical Cancer Undergoing Concurrent Chemoradiation Therapy.
    Adv Radiat Oncol. 2025;10:101879.
    PubMed    
    Abstract available

  49. MA Y, Lai X, Fang H
    Global, regional, and national disease burden and economic costs of cervical cancer (1991-2021): a multidimensional data synthesis analysis.
    Front Public Health. 2025;13:1633975.
    PubMed    
    Abstract available

  50. RAI H, Verma D, Meena R, Uniya U, et al
    Cervical Cancer Screening in HIV-Positive Women by Conventional Exfoliative Cytology and Liquid-Based Cytology.
    Cureus. 2025;17:e91118.
    PubMed    
    Abstract available

  51. MLAMBO A, Su S, Dhlamini Q, Zhang Y, et al
    Patterns of immune cell infiltration and oxidative stress in cervical cancer.
    Oncol Rev. 2025;19:1570071.
    PubMed    
    Abstract available

  52. LIU Y, Zhang X, Xin W, Ding Y, et al
    A long-term retrospective analysis of oncologic and fertility outcomes in cervical cancer patients undergoing radical trachelectomy.
    Front Oncol. 2025;15:1591923.
    PubMed    
    Abstract available

  53. LI B, Chen L, Sun C, Wang J, et al
    Leveraging deep learning for early detection of cervical cancer and dysplasia in China using U-NET++ and RepVGG networks.
    Front Oncol. 2025;15:1624111.
    PubMed    
    Abstract available

  54. SHI P, Zhang W, Yao Q, Yuan Z, et al
    Correction: CS Ratio is an immune-related prognostic biomarker for cervical cancer.
    Front Oncol. 2025;15:1697346.
    PubMed    
    Abstract available

  55. LUO S, Yin Y, Qiu L, Wang H, et al
    [Function evaluation of urinary, bowel, pelvic floor functions of patients after nerve-sparing radical hysterectomy based on CC-PRO137 scale].
    Zhonghua Yi Xue Za Zhi. 2025;105:3188-3194.
    PubMed    
    Abstract available

  56. BAVISHI L, Butani SB, Patel SS
    Small Interfering RNA (siRNA) Based Therapies for Cancer Treatment: A Special Focus on Cervical Cancer.
    Eur J Pharmacol. 2025 Sep 26:178198. doi: 10.1016/j.ejphar.2025.178198.
    PubMed    
    Abstract available

  57. HUANG Y, Lin W, Chen X, Zheng X, et al
    Analyzing and forecasting global cervical cancer burden based on WHO's elimination strategy: insights and projections from a 1990-2021 global burden of disease (GBD) study covering 204 countries and territories.
    J Adv Res. 2025 Sep 25:S2090-1232(25)00742-8. doi: 10.1016/j.jare.2025.
    PubMed    
    Abstract available

  58. MOSS JL, Bernacchi VE, Entenman J, Costigan H, et al
    Follow-Up After Receiving Abnormal Results From Self-Sampled Colorectal and Cervical Cancer Screening Tests Among Underserved Patients.
    Cancer Med. 2025;14:e71283.
    PubMed    
    Abstract available

  59. QIAO Y
    Eliminating cervical cancer: a global health imperative for women.
    Cancer Biol Med. 2025 Sep 26:j.issn.2095-3941.2025.0529.
    PubMed    


  60. CHETTA M, Rosati A, Bukvic N
    HPV as a Molecular Hacker: Computational Exploration of HPV-Driven Changes in Host Regulatory Networks.
    Viruses. 2025;17:1166.
    PubMed    
    Abstract available

  61. MENG X, Yang B, Yin H, Chen J, et al
    Global Burden and Incidence Trends in Cancers Associated with Human Papillomavirus Infection: A Population-Based Systematic Study.
    Pathogens. 2025;14:880.
    PubMed    
    Abstract available

  62. KAFASI A, Pitiriga VC, Spanakis N, Vlachos N, et al
    Evaluation of the PreTect HPV-Proofer E6/E7 mRNA Assay for the Detection of Precancerous Cervical Lesions in the Greek Female Population.
    Pathogens. 2025;14:853.
    PubMed    
    Abstract available

  63. ALABDULLATIF A, Almofty S, Tanimu G, Dafalla H, et al
    Tribulus terrestris-Mediated ZnO/Ag-Halloysite Nanohybrids for Targeted Cisplatin and Carboplatin Delivery in Cervical Cancer Treatment.
    Pharmaceuticals (Basel). 2025;18:1349.
    PubMed    
    Abstract available

  64. YORDANOV A, Tsoneva E, Hasan I, Kostov S, et al
    Sentinel Lymph Node Dissection-Novelty, Trend, or a Paradigm Shift in Surgical Decision-Making for Early Cervical Cancer?
    Medicina (Kaunas). 2025;61:1660.
    PubMed    
    Abstract available

  65. MARTINS TR, Levi JE
    Molecular Screening for Cervical Cancer.
    Genes (Basel). 2025;16:1041.
    PubMed    
    Abstract available

  66. LI J, Li S
    From Viral Infection to Genome Reshaping: The Triggering Role of HPV Integration in Cervical Cancer.
    Int J Mol Sci. 2025;26:9214.
    PubMed    
    Abstract available

  67. LEE KJ, Kim G, Seo B, Jeong SY, et al
    A Tissue Factor Bi-Specific T-Cell Engager Provides Effective Targeting and Cytotoxicity Against Cervical Cancer Cell Lines.
    Int J Mol Sci. 2025;26:8941.
    PubMed    
    Abstract available

  68. HABIB N, Idoubba S, Futcher F, Pieri E, et al
    Cervical Cancer Treatment and Fertility: What We Know and What We Do.
    Cancers (Basel). 2025;17:3057.
    PubMed    
    Abstract available

  69. PARULEKAR M, Kim MK, Noh JJ, Suh DH, et al
    Clinicopathological Factors Affecting Prognosis in Patients with Advanced Cervical Cancer Undergoing Concurrent Chemoradiation Therapy.
    Cancers (Basel). 2025;17:3042.
    PubMed    
    Abstract available

  70. GUITIAN M, Reina G, Carlos S
    The Role of Nutrition in HPV Infection and Cervical Cancer Development: A Review of Protective Dietary Factors.
    Cancers (Basel). 2025;17:3020.
    PubMed    
    Abstract available

  71. RESTIVO V, Graci D, Immordino A, Mancuso DG, et al
    Cervical Cancer Screening in Refugee and Migrant Populations: Results of Systematic Review and Meta-Analysis in Cross-Sectional and Cohort Studies.
    Cancers (Basel). 2025;17:2966.
    PubMed    
    Abstract available

  72. KOWALKOWSKA ME, Kaminska K, Wojtysiak J, Koper K, et al
    Tumor Mutational Burden in Cervical Cancer as Potential Marker for Immunotherapy Responders.
    Cancers (Basel). 2025;17:2963.
    PubMed    
    Abstract available

  73. NCANE Z, Gonah L, Estrada GAP, Faleni M, et al
    Knowledge, Attitudes, and Practices of Healthcare Workers on Cervical Cancer Screening in Rural Healthcare Facilities of the Eastern Cape.
    Healthcare (Basel). 2025;13:2316.
    PubMed    
    Abstract available

  74. YORDANOV A, Damyanova P, Vasileva-Slaveva M, Karakadieva K, et al
    Clinical Significance of Tumor Infiltrating T-Helper and Regulatory Cells in Bulgarian Cervical Cancer Patients.
    Biomedicines. 2025;13:2206.
    PubMed    
    Abstract available

  75. MASCARENHAS M, Martins M, Barroso L, Spindler L, et al
    Automated detection and classification of cervical and anal squamous cancer precursors using deep learning and multidevice colposcopy.
    Sci Rep. 2025;15:33068.
    PubMed    
    Abstract available

  76. GNANAGURUSAMY J, Sabanayagam R, Krishnamoorthy S, Balasubramanian V, et al
    EGCG remodels the TGF-beta cervical cancer micro-environment towards immune responsiveness.
    Cell Immunol. 2025;418:105027.
    PubMed    
    Abstract available

  77. ANDERER S
    Anal Cancer Risk Rises With Age and Time Among Cervical Cancer Survivors.
    JAMA. 2025 Sep 26. doi: 10.1001/jama.2025.13888.
    PubMed    


  78. GUPTA RD, Saha S, Rahman MA, Addo PNO, et al
    Factors influencing breast and cervical cancer screening among ever-married women aged 15-49 in Jordan: an analysis of the 2023 Jordan population and family health survey.
    J Egypt Natl Canc Inst. 2025;37:65.
    PubMed    
    Abstract available

  79. SANTIAGO-RODRIGUEZ EJ, Ramos TS, Ramos-Cartagena JM, Torres-Cintron CR, et al
    Effects of Hurricanes and the Coronavirus Disease 2019 (COVID-19) Pandemic on Cervical Cancer Diagnosis in Puerto Rico.
    O G Open. 2024;1:36.
    PubMed    
    Abstract available

  80. GAO C, Zhou Q, Liu L, Liu H, et al
    Stratification by Mutational Landscape Reveals Differential Immune Infiltration and Predicts the Recurrence and Clinical Outcome of Cervical Cancer.
    Phenomics. 2025;5:384-403.
    PubMed    
    Abstract available

  81. ALIMENA S, Lykken JM, Tiro JA, Chubak J, et al
    Accessibility of Criteria to Exit Cervical Cancer Screening at Age 65 Years in the Electronic Health Record.
    O G Open. 2024;1:32.
    PubMed    
    Abstract available

  82. LIU H, Zhang Z, Guo X, Wang T, et al
    The Effect of Bladder and Rectum Volume Changes on Exposed Organ Volume During Intensity-Modulated Radiotherapy for Cervical Cancer.
    Clin Med Insights Oncol. 2025;19:11795549251377910.
    PubMed    
    Abstract available


  83. Correction to "Catastrophic Venous and Arterial Thrombosis in a Young Female With Cervical Cancer".
    EJHaem. 2025;6:e70149.
    PubMed    
    Abstract available

  84. CHEN S, Li T, Wang Y, Dai Y, et al
    The Impact of Specific Sexually Transmitted Pathogens on Cervix: A Prospective Study Based on Cervical Cancer Screening Cohort.
    J Med Virol. 2025;97:e70616.
    PubMed    
    Abstract available

  85. MABUCHI S, Komura N, Nakamura H, Maeda M, et al
    The activity of immune checkpoint inhibitors in patients with recurrent cervical cancer developed in previously irradiated field: clinical and immunohistochemical investigations.
    J Gynecol Oncol. 2025 Sep 15. doi: 10.3802/jgo.2026.
    PubMed    
    Abstract available

  86. JIN XH, Liu XM, Huang HY
    The mediating role of medical coping modes between anxiety and fear of progression in patients with cervical intraepithelial neoplasia grade 3: a cross-sectional survey.
    BMC Psychol. 2025;13:1019.
    PubMed    
    Abstract available

  87. SALEHI AM, Shahbazi F, Garavand R, Kamkari S, et al
    Global socioeconomic inequalities in breast, cervical, ovarian, and uterine cancers incidence, mortality, disability-adjusted life year's rates: a relative concentration index analysis.
    BMC Womens Health. 2025;25:433.
    PubMed    
    Abstract available

  88. SYDING LA, Plackova K, Pavelkova L, Aquino-Perez C, et al
    High Treg and PMN-MDSC densities are a hallmark of tertiary lymphoid structures in fatal cases of cervical cancer.
    J Immunother Cancer. 2025;13:e012613.
    PubMed    
    Abstract available

  89. TAL S, Vowels JA, Gonzalez D, Polychronopoulou E, et al
    Performance Evaluation of the Aptima hrHPV Nucleic Acid Amplification and Papanicolaou Co-Testing in Cervical Cancer Screening: Insights from a Diverse Population-Based Retrospective Study.
    J Mol Diagn. 2025 Sep 23:S1525-1578(25)00218.
    PubMed    
    Abstract available

  90. CHEN W, Liu C, Li S, Xie X, et al
    ZC3H18 regulates alternative splicing and related genes in cervical cancer.
    Front Genet. 2025;16:1621238.
    PubMed    
    Abstract available

  91. ZHANG L, Zhang Q, Pang B, Tan Z, et al
    Epidemiological characteristics and risk factors of high-risk HPV infection, cervical cancer, and precancerous lesions among women in Southwestern China.
    Front Oncol. 2025;15:1645748.
    PubMed    
    Abstract available

  92. LI W, Wang X, Wu M, Tan X, et al
    Quality of life in cervical cancer survivors after nerve-sparing radical hysterectomy, conventional radical hysterectomy or concurrent chemoradiotherapy.
    Front Oncol. 2025;15:1654730.
    PubMed    
    Abstract available

  93. VASIC J, Prvulovic Bunovic N, Saroskovic M, Vukovic J, et al
    The apparent diffusion coefficient as a biomarker in the diagnosis of cervical cancer and the assessment of therapeutic response to chemoradiation therapy.
    Front Oncol. 2025;15:1610090.
    PubMed    
    Abstract available

  94. KUBURA D, Sampson S, Erekosima G, Dauda M, et al
    Stakeholders' perspectives on lessons learnt from HPV mass vaccination in Nigeria.
    BMC Public Health. 2025;25:3062.
    PubMed    
    Abstract available

  95. ZIDI S, Almawi WY, Abassi S, Khadraoui N, et al
    Genital mycoplasma infections: a hidden factor in cervical cancer progression? A systematic review and meta-analysis.
    BMC Infect Dis. 2025;25:1120.
    PubMed    
    Abstract available

  96. QIAN H, Tang M, Wu T, Sun Z, et al
    The Role of Replication Stress-Related Genes in Cervical Cancer Radiotherapy Resistance: A Bioinformatic and Experimental Validation.
    Lab Invest. 2025 Sep 22:104244. doi: 10.1016/j.labinv.2025.104244.
    PubMed    
    Abstract available

  97. VAN SCHALKWYK C, Meyer-Rath G, Masuku S, Jamieson L, et al
    Cost-effectiveness of different HPV vaccination strategies for cervical cancer prevention in South Africa.
    Vaccine. 2025;64:127770.
    PubMed    
    Abstract available

  98. TWABI HH, Sibande W, Mhango O, Msosa TC, et al
    Acceptability of self-sampling for high-risk HPV DNA testing for primary cervical cancer screening among women in Thyolo, Malawi: A qualitative study.
    PLOS Glob Public Health. 2025;5:e0004763.
    PubMed    
    Abstract available

  99. KIM M, Lee M, Kang J, Lee SJ, et al
    HPV ctDNA as a Biomarker for Monitoring Disease Progression in HPV16/18-Associated Cervical Cancer.
    Pathobiology. 2025 Sep 24:1-15. doi: 10.1159/000548452.
    PubMed    
    Abstract available

  100. STOLNICU S, Talia KL, Banet N, McCluggage WG, et al
    Lymphovascular Space Invasion in Cervical Cancer: A Review of Clinical Significance and Pathologic Issues.
    Int J Gynecol Pathol. 2025 Sep 3. doi: 10.1097/PGP.0000000000001135.
    PubMed    
    Abstract available

  101. LEE GH, Kim S, Kim SH, Lee ES, et al
    Transcription cascade reaction-driven isothermal amplification for ultrasensitive detection of high-risk human papillomavirus.
    Biosens Bioelectron. 2025;290:117984.
    PubMed    
    Abstract available

  102. WIJENAYAKE N, Ladino D, Patterson K, Rosim M, et al
    Evaluating the broad societal value of pembrolizumab in women's cancer in Brazil.
    J Med Econ. 2025;28:1651-1668.
    PubMed    
    Abstract available

  103. SUN W, Angelova A, Han X, Wang X, et al
    Self-Assembling Amphiphilic Peptides Target the VDAC1-Hexokinase-II Complex to Induce Apoptosis in Cervical Carcinoma Cells.
    J Med Chem. 2025;68:18857-18868.
    PubMed    
    Abstract available

  104. CHEN Q, Wang H, Zhang H, Zhu Z, et al
    EdgeNeXt-SEDP for cervical adenocarcinoma HPV-associated and non-HPV-associated diagnosis and decision support.
    Life Sci. 2025;380:123931.
    PubMed    
    Abstract available

  105. BROOKS RT, Hulshizer CA, Hanson AC, Davis JM 3rd, et al
    Cumulative Incidence of Cancer Screening for Breast, Cervical, Prostate, and Colorectal Cancer in Patients with Rheumatoid Arthritis.
    J Rheumatol. 2025 Jul 25:jrheum.2025-0190. doi: 10.3899/jrheum.2025-0190.
    PubMed    
    Abstract available

  106. SMITH DG, Dantes EM, Beyl R, de Koter YXA, et al
    Perceived Risk and HPV Vaccination Awareness Among Women in Rural and Underserved Communities in the State of Louisiana.
    J Community Health. 2025;50:826-832.
    PubMed    
    Abstract available

  107. NAKAMURA K, Masuda K, Seki T, Kitago M, et al
    Potential New Tumors Associated with Hereditary Breast and Ovarian Cancer (HBOC).
    Keio J Med. 2025;74:158-161.
    PubMed    
    Abstract available

  108. TAO YC, Guo LC, Guo X, Huang RP, et al
    [Expression of keratin 1/sialyl-Tn antigen in primary and metastatic cervical squamous cell carcinomas].
    Zhonghua Bing Li Xue Za Zhi. 2025;54:1069-1074.
    PubMed    
    Abstract available

  109. WANG S, Yang X, Gao Z, Zhao M, et al
    The risk of Radiation-Associated second cancer in patients with cervical cancer following radiotherapy from 1975-2019.
    Oncologist. 2025 Oct 10:oyaf334. doi: 10.1093.
    PubMed    
    Abstract available

  110. MOUSAVINEJAD SN, Lachouri R, Ferdosi F, Khatami SH, et al
    Cervical cancer diagnostics: non-coding RNAs and biosensors to AI-derived methods.
    Clin Chim Acta. 2025 Oct 8:120641. doi: 10.1016/j.cca.2025.120641.
    PubMed    
    Abstract available

  111. AHMED A, Karsany M, Abdelwadoud M, Ali M, et al
    MOLECULAR DETECTION OF HIGH RISK HUMAN PAPILLOMA VIRUS SUBTYPES IN CERVICAL SMEARS AMONG SUDANESE WOMEN.
    Georgian Med News. 2025;.
    PubMed    
    Abstract available

  112. KURIATA N, Mazur KZ, Saemundarson MM, Urosevic Z, et al
    A Novel NGS-Based Algorithm for Precise HPV Genotyping and Co-infection Detection in QCMD Samples and FFPE Tissues.
    Curr Protoc. 2025;5:e70231.
    PubMed    
    Abstract available

  113. NAMOOS A, Abosamak N, Sheppard V
    A Pilot Study: Adaptation Phase of the PROMIS Women Education Program-Promoting Cervical Cancer Prevention Methods Among Muslim Women in Virginia.
    Cancer Med. 2025;14:e71296.
    PubMed    
    Abstract available

  114. TURUNEN IJ, Kalliala I, Pankakoski M, Partanen VM, et al
    High risk human papillomavirus versus cytological screening over two rounds in Finnish screening programme for cervical cancer: population based cohort study.
    BMJ Med. 2025;4:e001435.
    PubMed    
    Abstract available

  115. CIZICENO M, Bertolazzi A, Quaglia V
    Examining cervical cancer screening adherence: how does healthism influence participation?
    BMC Public Health. 2025;25:3420.
    PubMed    


  116. LO SHS, Chau JPC, Choi KC, Butt L, et al
    Effects of an educational health promotion intervention to improve human papillomavirus vaccination acceptance and uptake among adolescent girls: a cluster randomized controlled trial.
    BMC Public Health. 2025;25:3419.
    PubMed    
    Abstract available

  117. CAI W, Wang Y, Yan X, Zhou P, et al
    Successful use of ovarian vein as a ureteral substitute for long-segment ureteral stricture post-pelvic radiotherapy: a case report.
    BMC Surg. 2025;25:460.
    PubMed    
    Abstract available

  118. TIRO JA, Metcalfe S, Muthukrishnan M, Jose A, et al
    Promoting cervical cancer screening via a mailed HPV self-collection kit: Reactions from screeners and non-screeners.
    Patient Educ Couns. 2025;142:109374.
    PubMed    
    Abstract available

  119. EKATERINA K, Andreas Martin K, Irakli K, Elene K, et al
    Artificial intelligence generated visual communication improves comprehension and adherence in cervical cancer screening: a randomized controlled study.
    Int J Med Inform. 2025;205:106134.
    PubMed    
    Abstract available

  120. ZHANG X, Dong X, Starr D, Bai X, et al
    Assessment of the efficiency and accuracy of an artificial intelligence assistive system in the diagnosis of Pap cervical atypical glandular cell cytology.
    Cancer Cytopathol. 2025;133:e70056.
    PubMed    
    Abstract available

  121. C K, Kannan Karur A, C C, V P, et al
    Knowledge, Attitudes, and Practices of Medical Professionals Regarding Cervical Cancer Prevention and Human Papillomavirus (HPV) Vaccination: A Cross-Sectional Study.
    Cureus. 2025;17:e91754.
    PubMed    
    Abstract available

  122. WANG Y, Wu D, Gai J, Cai Y, et al
    Elevated VAMP8 expression promotes cervical cancer progression by enhancing autophagy via HIF-1 pathway.
    BMC Med. 2025;23:544.
    PubMed    
    Abstract available

  123. PEI K, Xi M
    The effect of marital status on cervical cancer related prognosis: a propensity score matching study.
    Sci Rep. 2025;15:35166.
    PubMed    
    Abstract available

  124. BAYISA K, Chibsa SE, Tesfaye H, Kefeni BT, et al
    Cervical cancer screening utilization and associated factors among women living with HIV in South West Ethiopia.
    Sci Rep. 2025;15:35081.
    PubMed    
    Abstract available

  125. SU L, Xu R, Ren Y, Meng C, et al
    Smoking exposure and cervical cancer risk: Integrating observational and genetic evidence.
    J Int Med Res. 2025;53:3000605251383687.
    PubMed    
    Abstract available

  126. HAYASHI R, Hara A, Iwasa Y
    Human papillomavirus driving cervical cancer: A mathematical model with persistent infection, cancer progression, and spontaneous remission.
    J Theor Biol. 2025 Oct 6:112289. doi: 10.1016/j.jtbi.2025.112289.
    PubMed    
    Abstract available

  127. KAVUMA A, Kibudde S, Kanyike DM, Luutu I, et al
    Impact of Waiting Time and Treatment Duration on Short-Term Outcomes for Patients With Locally Advanced Cervical Cancer at the Uganda Cancer Institute: The Challenges in Resource-Limited Settings.
    JCO Glob Oncol. 2025;11:e2500325.
    PubMed    
    Abstract available

  128. ZHANG T, Gu F, Li W, Han R, et al
    Characterization of cervical microbiota in cervical intraepithelial neoplasia and cervical cancer using low-coverage whole genome sequencing.
    Microbiol Spectr. 2025 Oct 8:e0320624. doi: 10.1128/spectrum.03206.
    PubMed    
    Abstract available

  129. FENG S, Yin Y, Guo H, Li D, et al
    Leukemoid Reaction and Sudden Hearing Loss in Early Cervical Cancer: A Case Report and Review of the Literature.
    Int J Womens Health. 2025;17:3417-3422.
    PubMed    
    Abstract available

  130. RYCHLIK A, Bedynska M, Querleu D
    Correspondence on "Robotic radical hysterectomy for cervical cancer: current trends and controversies".
    J Cancer. 2025;16:3897-3898.
    PubMed    


  131. JIANG L, Okada A, Ishida R, Yasunaga H, et al
    Association Between Metabolic Syndrome and Incident Cervical Cancer: A Retrospective Cohort Study.
    J Obes. 2025;2025:3691654.
    PubMed    
    Abstract available

  132. SVINTSITSKA A, Lygyrda N, Svintsitskyi V, Borikun T, et al
    INTERPLAY OF EPIGENETIC REGULATION OF KI-67 AND P53 BY MIR-21 AND MIR-34A IN CERVICAL INTRAEPITHELIAL NEOPLASIA.
    Exp Oncol. 2025;47:223-229.
    PubMed    
    Abstract available

  133. HALDER P, Sharma D, Behera A, Aggarwal AK, et al
    Decomposition analysis of coverage of cervical cancer screening among Indian women within reproductive age-group: distribution and determinants of socioeconomic inequalities using a nationally representative survey.
    Reprod Health. 2025;22:188.
    PubMed    
    Abstract available

  134. KUGUYO O, Matimba A, Tsikai N, Madziyire M, et al
    Association between human papillomavirus and behaviour, clinicopathology, and cervical cancer outcome in Zimbabwean women: a cross-sectional study.
    Reprod Health. 2025;22:190.
    PubMed    
    Abstract available

  135. YE Y, Hu X, Zhang X, Xu X, et al
    A prospective longitudinal study of the changes in multidimensional fatigue and its associated factors in patients undergoing brachytherapy for cervical cancer.
    Sci Rep. 2025;15:34831.
    PubMed    
    Abstract available

  136. TITUS MK, Giesbrecht D, Oduor CI, Muthoka K, et al
    Scalable long-read nanopore HPV16 amplicon-based whole-genome sequencing.
    Sci Rep. 2025;15:34892.
    PubMed    
    Abstract available

  137. MA C, Lu X, Ni C, Gao Y, et al
    SLC25A10 promotes cisplatin resistance by inhibiting ferroptosis in cervical cancer.
    Cell Death Discov. 2025;11:447.
    PubMed    
    Abstract available

  138. NIE R, Ma Z, Rui X, Li T, et al
    HPV vaccination willingness and behavior among nursing female students in China based on the protection motivation theory: A cross-sectional study.
    Hum Vaccin Immunother. 2025;21:2569738.
    PubMed    
    Abstract available

  139. DENG L, Zhang R, Lv H, Li F, et al
    Multi-parametric MRI Radiomics models for preoperative assessment of lymph vascular space invasion status in early-stage cervical cancer: A two-center retrospective study.
    Br J Radiol. 2025 Oct 7:tqaf248. doi: 10.1093.
    PubMed    
    Abstract available

  140. RUBEN C, Narasimhan S, Nolan E
    EBM BLS: Self-collected Human Papillomavirus Cervical Cancer Screening Is Non-Inferior to Clinician-Collected Samples.
    J Gen Intern Med. 2025 Oct 7. doi: 10.1007/s11606-025-09830.
    PubMed    


  141. SCHEEPERS VC, Gardner J
    Expanding the case for gender-neutral human papillomavirus vaccination in South Africa: Emerging neonatal and ethical considerations.
    Afr J Prim Health Care Fam Med. 2025;17:e1-e3.
    PubMed    
    Abstract available

  142. ZHU L, Pu J, Tao Y, Shi L, et al
    A therapeutic multi-epitope protein vaccine targeting HPV16 E6 E7 elicits potent tumor regression and cytotoxic immune responses.
    Cancer Biol Med. 2025;22:1102-26.
    PubMed    
    Abstract available

  143. MA S, Sun K, Han B, Zheng R, et al
    Cervical cancer burden and trends in China, 2000-2020: Asia-Pacific international comparisons and insights for elimination goals.
    Cancer Biol Med. 2025;22:1017-35.
    PubMed    
    Abstract available

  144. ZHONG P, Zhang L, Zhao F
    Modeling cervical cancer elimination: a pathway to inform policy decisions.
    Cancer Biol Med. 2025;22:1002-9.
    PubMed    


  145. REZHAKE R, Abuduxikuer G, Abudurexiti G, Zhuo Q, et al
    Evaluation of the multiple HPV-based "screen and triage" algorithms in real-world settings of rural China.
    Cancer Biol Med. 2025;22:1053-67.
    PubMed    
    Abstract available

  146. CHEN M, Ma J, Wu Y, Hu H, et al
    Accelerating the elimination of global cervical cancer through intelligent training for colposcopy.
    Cancer Biol Med. 2025;22:1036-52.
    PubMed    
    Abstract available

  147. KAMIJO S, Matsuda R, Yamada M, Nishio H, et al
    Outcomes of assisted reproductive technology after radical abdominal trachelectomy for early-stage cervical cancer.
    F S Rep. 2025;6:299-308.
    PubMed    
    Abstract available

  148. TALI H, Yeerjiang K, Zeng BB, Rui T, et al
    Barriers to cervical cancer prevention and triage strategies: a study of knowledge, attitudes, and p16/Ki-67 dual-staining utility among high-risk women in Tuoli and Fuyun counties, Xinjiang.
    PeerJ. 2025;13:e20100.
    PubMed    
    Abstract available

  149. QI H, Liu X, Sun J, Dong L, et al
    Key cell cycle genes in cervical cancer and their potential role in neuromuscular complications: a bioinformatics perspective.
    Eur J Transl Myol. 2025 Oct 6. doi: 10.4081/ejtm.2025.14127.
    PubMed    
    Abstract available

  150. TOGAMI S, Furuzono N, Kobayashi Y, Fukuda M, et al
    Fertility-Sparing Trachelectomy With Sentinel Node Mapping in Early-Stage Cervical Cancer: Oncological Safety and Obstetric Outcomes From a Single-Institution Study.
    J Obstet Gynaecol Res. 2025;51:e70091.
    PubMed    
    Abstract available

  151. ZHANG X, Li M, Wang K, Sun Z, et al
    A histone acetylation-based predictive model for immunotherapy response and combinatorial targeting in cervical cancer.
    Medicine (Baltimore). 2025;104:e44946.
    PubMed    
    Abstract available

  152. XING G, Lu Y, Zhang C, Sun X, et al
    Primary vaginal adenocarcinoma as a radiation-associated secondary malignancy: A case report and comprehensive literature review.
    Medicine (Baltimore). 2025;104:e44272.
    PubMed    
    Abstract available

  153. ZHU M, Zhang Y, Bao X, Zhu H, et al
    Association between childhood adiposity and gynecologic cancers: a mendelian randomization analysis.
    BMC Womens Health. 2025;25:470.
    PubMed    
    Abstract available

  154. AYNALEM BY, Anteneh KT, Enyew MM
    Knowledge, attitudes, and associated factors of cervical cancer screening among women in Debre Markos town, Northwest Ethiopia: a cross-sectional study.
    Sci Rep. 2025;15:34726.
    PubMed    
    Abstract available

  155. SWASE TD, Agunloye MO, Ifie JE, Shinkafi TS, et al
    The Impact of Antiretroviral Therapy (ART) on HPV Persistence and Cervical Cancer Progression Among Women with HPV/HIV Co-infection: A Systematic Review.
    AIDS Behav. 2025 Oct 6. doi: 10.1007/s10461-025-04835.
    PubMed    
    Abstract available

  156. HU J, Wang H, Zhao S, Huang L, et al
    Participation, knowledge, and attitudes toward cervical cancer screening among migrant Burmese women on China-Myanmar border: a cross-sectional study.
    Prev Med Rep. 2025;58:103205.
    PubMed    
    Abstract available

  157. WEI ZT, Yu XW, He JX, Liu Y, et al
    Erratum: [Corrigendum] Characteristics of primary side population cervical cancer cells.
    Oncol Lett. 2025;30:547.
    PubMed    
    Abstract available

  158. TAHA H, Alhawamdeh T, Alkhaldi SM, Ali Albsoul R, et al
    Knowledge and attitudes of medical students regarding human papilloma virus infection and vaccine: cross-sectional study from Jordan.
    Front Cell Infect Microbiol. 2025;15:1657090.
    PubMed    
    Abstract available

  159. GU X, Luo Y, Lai C, Liu Y, et al
    Analysis of Risk Factors of Lymphedema After Surgical Treatment in Cervical Cancer: A Case-Control Retrospective Study.
    Int J Gen Med. 2025;18:5927-5938.
    PubMed    
    Abstract available

  160. WU F, Tang X, Liu W, Luo Z, et al
    Efficacy of Endostar plus concurrent chemoradiotherapy in locally advanced cervical cancer: a multicenter, phase II randomized trial.
    Ther Adv Med Oncol. 2025;17:17588359251379397.
    PubMed    
    Abstract available

  161. MACHABA SIKHWETHA MC, Makhado L
    Experiences of women living with HIV who underwent long loop excision of the transformation zone (LLETZ) in selected hospitals of Vhembe district, Limpopo province, South Africa.
    F1000Res. 2025;14:382.
    PubMed    
    Abstract available

  162. WEN W, Li J, Yuan L, Liao Y, et al
    PRDX3 Promotes Lymph Node Metastasis in Cervical Cancer by Activating NF-kappaB Signaling Pathway and Anoikis Resistance.
    Int J Med Sci. 2025;22:3839-3853.
    PubMed    
    Abstract available

  163. CHIBA T, Nakamura S, Nakayama H, Iijima K, et al
    Dosimetric impact of dose constraint indications using individual patient dose management system for brachytherapy in cervical cancer.
    J Contemp Brachytherapy. 2025;17:255-266.
    PubMed    
    Abstract available

  164. ELBANNA M, Agrawal N, Holmes JA
    Predictors of interstitial brachytherapy utilization in locally advanced cervical cancer and impact on overall survival.
    J Contemp Brachytherapy. 2025;17:248-254.
    PubMed    
    Abstract available

  165. HAO F, Xiao N, Wang M, Sang H, et al
    Clinical Prognostic Factors for Overall Survival in Patients Undergoing Radical Radiotherapy for Cervical Cancer.
    Int J Womens Health. 2025;17:3347-3359.
    PubMed    
    Abstract available

  166. MUSHASHA MP, Modiba LM
    Awareness among nurses concerning the human papilloma virus in the selected clinics in Vhembe district of Limpopo Province, South Africa.
    Front Public Health. 2025;13:1627425.
    PubMed    
    Abstract available

  167. OU Y, Chokkakula S, Chong SM, Wang H, et al
    Age and socioeconomic disparities in cervical cancer incidence and mortality: a SEER-based analysis.
    Front Public Health. 2025;13:1591883.
    PubMed    
    Abstract available

  168. ASOUDEH-FARD A, Parsaei A, Hejazian SM, Asoudeh-Fard M, et al
    Combinational therapy of cervical cancer consisting of probiotic particles and vincristine: a molecular in vitro study.
    Med Oncol. 2025;42:509.
    PubMed    
    Abstract available

  169. ARAGAW GM, Aynalem GL, Abiy SA, Taye EB, et al
    Knowledge and attitude of parents towards the human papillomavirus vaccine for their daughters and associated factors in Debre Tabor town, northwest Ethiopia: a community-based cross-sectional study.
    BMJ Open. 2025;15:e088550.
    PubMed    
    Abstract available

  170. VAN SCHALKWYK C, Meyer-Rath G, Masuku S, Jamieson L, et al
    Corrigendum to "Cost-effectiveness of different HPV vaccination strategies for cervical cancer prevention in South Africa" [Vaccine 64 (2025) 127770].
    Vaccine. 2025;65:127797.
    PubMed    


  171. NIRMALKAR AP, Shahabuddin SM, Mahajan US, Mamulwar MS, et al
    Cervical Cancer Screening Methods among Women Living with Human Immunodeficiency Virus: A Systematic Review and Meta-analysis.
    Indian J Public Health. 2025;69:321-331.
    PubMed    
    Abstract available

  172. BONATTI M, Valletta R, D'Erme L, Dolciami M, et al
    Preoperative staging of cervical cancer: time to shift from cystoscopy to MRI.
    Eur Radiol. 2025 Oct 4. doi: 10.1007/s00330-025-12039.
    PubMed    
    Abstract available

  173. HUANG Y, Zhong Y, Lu H, Jin K, et al
    In Situ Construction of Upconverting Nano-Bacteria Biohybrids via Biomimetic Mineralization for Synergistic Antitumor Phototherapy.
    ACS Appl Mater Interfaces. 2025;17:56006-56016.
    PubMed    
    Abstract available

  174. WEI J, Zou K, Sun F, Feng Q, et al
    18 F-FAPI-04 PET/CT in the Evaluation of Patients With Cervical Cancers : Head-to-Head Comparison With 18 F-FDG PET/CT.
    Clin Nucl Med. 2025 Aug 21. doi: 10.1097/RLU.0000000000006103.
    PubMed    
    Abstract available

  175. GUAN W, Liu S, Chen Y, Chu C, et al
    HPVPool-Seq: a genotype-guided pooling strategy for cost-effective next-generation sequencing detection of HPV integration in cervical samples.
    Microbiol Spectr. 2025;13:e0139925.
    PubMed    
    Abstract available

  176. GUILLAUME D, Alcaide ML, Sternberg CA, Hay J, et al
    Contextualizing HPV vaccination intention among Haitian immigrant and migrant women through exploring cultural worldviews and affective risk perception: a qualitative study.
    Ethn Health. 2025;30:806-823.
    PubMed    
    Abstract available

  177. BEFANO B, Kalpathy-Cramer J, Egemen D, Inturrisi F, et al
    Initial evaluation of a new cervical screening strategy combining human papillomavirus genotyping and automated visual evaluation: the Human Papillomavirus-Automated Visual Evaluation Consortium.
    J Natl Cancer Inst. 2025;117:2124-2129.
    PubMed    
    Abstract available

  178. PRITCHARD AG, Altas M, Tinker AV, Kong I, et al
    Long-Term Toxicities of Adolescent and Young Adults Who Underwent Radiation Therapy for Cervix Cancer: A Cross-Sectional Analysis.
    J Adolesc Young Adult Oncol. 2025;14:392-400.
    PubMed    
    Abstract available

  179. LIU L, Storino M, Chen YS, Walker A, et al
    Mesonephric and Mesonephric-like Adenocarcinomas of the Gynecologic Tract: A Case Series and a Review of the Literature.
    Int J Gynecol Pathol. 2025;44:553-560.
    PubMed    
    Abstract available

  180. BAENA A, Picconi MA, Mendoza L, Ferrera A, et al
    Short-term repeat HPV testing for triaging HPV-positive women in cervical cancer screening.
    Br J Cancer. 2025 Oct 3. doi: 10.1038/s41416-025-03193.
    PubMed    
    Abstract available

  181. THAKUR S, Suteri P, Sharma DN, Mathur S, et al
    A Sneak Peek Into a Rare Case of Metastatic Cervix Adenocarcinoma in Pleural Fluid With an Approach to Diagnosis.
    Cytopathology. 2025;36:619-622.
    PubMed    
    Abstract available

  182. TOYODA S, Morita K, Ito F, Niiro E, et al
    Large Cell Neuroendocrine Carcinoma of the Uterine Cervix With a Biphasic Synaptophysin Staining Pattern and Followed Vaginal Intraepithelial Recurrence: A Case Report.
    Cytopathology. 2025;36:602-605.
    PubMed    
    Abstract available

  183. GIACHINI C, Pompeo G, Puliti D, Gorini G, et al
    From the Daily Peer Review of Abnormal Pap Test Slides to the Monitoring of Individual and Laboratory Performances: 5 Years of Data Collection and New Potential (Key) Performance Indicators.
    Cytopathology. 2025;36:558-567.
    PubMed    
    Abstract available

  184. KINKOROVA LUNACKOVA I, Ondic O, Nemcova J, Cerna K, et al
    The Methylation Test Is Highly Sensitive for HPV-Associated Endocervical Adenocarcinoma and Could Be Helpful as a Cytological Ancillary Test in Women With a PAP-Smear Diagnosis of Severe Glandular Lesion (AGC-NEO+).
    Cytopathology. 2025;36:568-571.
    PubMed    
    Abstract available

  185. SOOD N, Gupta R, Gupta S
    Villoglandular Carcinoma of the Uterine Cervix: Clinic-Cytopathological-Histological Features of a Rare Case With Brief Review of the Literature.
    Cytopathology. 2025;36:596-601.
    PubMed    
    Abstract available

  186. TANAKA K, Lami K, Odate T, Hori T, et al
    Cytology Screening Using Z-Stack Digital Slides: A Validation Study.
    Diagn Cytopathol. 2025;53:568-575.
    PubMed    
    Abstract available

  187. ZHOU Q, Luo K, Zhao L
    A Study on the Impact of HPV Genotype Infection Patterns on the Occurrence of High-Grade Squamous Intraepithelial Lesion.
    Diagn Cytopathol. 2025;53:529-535.
    PubMed    
    Abstract available

  188. KOCIAN R, Kohler C, Klat J, Jarkovsky J, et al
    Sentinel lymph node mapping in early-stage cervical cancer: Results from the SENTIX prospective multicenter study.
    Gynecol Oncol. 2025;202:118-124.
    PubMed    
    Abstract available

  189. CHASE DM, Huang HQ, Deng W, Koh WJ, et al
    Patient-reported outcomes of a randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate risk, stage I/IIA cervical cancer patients treated with initial radical hysterectomy and pelvic lymphadenectomy (NRG/GOG-026
    Gynecol Oncol. 2025;202:102-109.
    PubMed    
    Abstract available

  190. ZHONG F, Ren Z, Li W, Jones T, et al
    The sensitivity and specificity of Claudin18.2 and MUC6 in the differential diagnosis of endocervical gastric-type glandular lesions.
    Hum Pathol. 2025;160:105837.
    PubMed    
    Abstract available

  191. SINGLA A, Mehta S, Grover A, Mishra AK, et al
    Cervical cancer screening: Is self-sampling the answer?
    Int J Gynaecol Obstet. 2025 Sep 30. doi: 10.1002/ijgo.70562.
    PubMed    
    Abstract available

  192. MURAD V, Chawla T, Brien CO
    The missing link in SHAPE: standardizing magnetic resonance imaging assessment of stromal invasion for cervical cancer.
    Int J Gynecol Cancer. 2025;35:102133.
    PubMed    


  193. DIAZ ES, Levin G, Aristizabal B, Fernandes A, et al
    Silicon dioxide, sodium selenite and citric acid vaginal gel, HPV infection, and cervical preinvasive disease: a narrative review.
    Int J Gynecol Cancer. 2025;35:102021.
    PubMed    
    Abstract available

  194. SONG Y, Qin H, Huang S, Wang J, et al
    alpha-hederin inhibits cervical cancer progression by inducing DNA damage-dependent cell cycle blockade and apoptosis.
    BMC Cancer. 2025;25:1503.
    PubMed    
    Abstract available

  195. LI X, Mao Z, Li Q, He M, et al
    Prognostic factors of locally advanced cervical cancer after concurrent chemoradiotherapy: a retrospective study.
    BMC Cancer. 2025;25:1498.
    PubMed    
    Abstract available

  196. BRUNO MT, Cavallaro AG, Sudano MC, Fratto MC, et al
    Role of endocervical curettage in detecting CIN2 + in postmenopausal women with persistent high-risk HPV and type 3 transformation zone.
    BMC Cancer. 2025;25:1486.
    PubMed    
    Abstract available

  197. WYATT LC, Nguyen CH, LeCroy MN, Foster V, et al
    Prevalence of breast, cervical, and colorectal cancer screenings among select New York City populations.
    BMC Cancer. 2025;25:1469.
    PubMed    
    Abstract available

  198. KONG L, Xiao X, Wan R, Zhao S, et al
    Immediate risk and 5-year cumulative risk of high-grade cervical lesions in high-risk HPV-positive patients with minor cytological abnormalities: a retrospective single-center study in China.
    BMC Cancer. 2025;25:1541.
    PubMed    
    Abstract available

  199. LAI R, Tan Q, Ding C, Xu Y, et al
    Habitat-based transformer model in pretreatment (18)F-FDG PET imaging for predicting prognosis in cervical cancer: a two-center retrospective study.
    BMC Cancer. 2025;25:1515.
    PubMed    
    Abstract available

  200. ZHU J, Zhou Q, Chen L, He Z, et al
    Predicting hematologic toxicity in advanced cervical cancer patients using interpretable machine learning models based on radiomics and dosimetrics.
    BMC Cancer. 2025;25:1516.
    PubMed    
    Abstract available

  201. MURENZI G, Kanyabwisha F, Demarco M, Muhoza B, et al
    Determinants of cervical high-risk human papillomavirus positivity among Rwandan women living with human immunodeficiency virus.
    PLoS One. 2025;20:e0333077.
    PubMed    
    Abstract available

  202. KAMAU SW, Jepkorir M, Kipkoech G, Lagu IJL, et al
    Antiproliferative activity of Grewia villosa ethyl acetate extract on cervical cancer HeLa cell line: Mechanistic insights through network pharmacology and functional assays approach.
    PLoS One. 2025;20:e0331649.
    PubMed    
    Abstract available

  203. ADISU MA, Habtie TE, Kitaw TA, Gessesse AD, et al
    The rising burden of female cancer in Ethiopia (2000-2021) and projections to 2040: Insights from the global burden of disease study.
    PLoS One. 2025;20:e0333787.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;